Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Maria V. Barabanshikova"'
Autor:
Evgenij Bakin, Ludmila S. Zubarovskaya, Maria V. Barabanshikova, Ivan S. Moiseev, Elena V. Morozova, Ildar M. Barkhatov, Alexander D. Kulagin, Boris V. Afanasyev, TL Gindina, Yulia Vlasova, Tatyana V. Shneider, Ksenia Jurovskaya
Publikováno v:
Cellular Therapy and Transplantation. 9:20-28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ff88f77e77bd93b2625d7218a4ffb04
https://doi.org/10.18620/ctt-1866-8836-2020-9-4-20-28
https://doi.org/10.18620/ctt-1866-8836-2020-9-4-20-28
Autor:
Elena V. Morozova, Anna A. Osipova, Elena I. Darskaya, Boris V. Afanasyev, Varvara N. Ovechkina, Maria V. Barabanshikova, Alexander L. Alyanskiy, Tatiana A. Rudakova, Sergey N. Bondarenko, Alexander D. Kulagin, TA Bykova, Ivan S. Moiseev, Anastasia V. Beinarovich
Publikováno v:
Cellular Therapy and Transplantation. 8:38-44
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d47bf1cacdf7d0f0a8e308b630c9c9d9
https://doi.org/10.18620/ctt-1866-8836-2019-8-2-38-44
https://doi.org/10.18620/ctt-1866-8836-2019-8-2-38-44
Autor:
Nikolai Yu. Tcvetkov, Elena I. Darskaya, Sergey N. Bondarenko, Elena V. Morozova, Julia V. Rudnitskaya, Maria V. Barabanshikova, Boris V. Afanasyev, Ksenia V. Melsitova, Ivan S. Moiseev
Publikováno v:
Cellular Therapy and Transplantation. 8:36-45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5687d455ff756cb826e696f80c59139c
https://doi.org/10.18620/ctt-1866-8836-2019-8-1-36-45
https://doi.org/10.18620/ctt-1866-8836-2019-8-1-36-45
Autor:
Maria V. Barabanshikova, Boris V. Afanasyev, Artem Gusak, Ivan S. Moiseev, Julia J. Vlasova, Elena V. Morozova, Kirill V. Lepik, E.A. Bakin, V. Baykov, Ludmila S. Zubarovskaya, Nikolai Yu. Tcvetkov, Anna A. Osipova
Publikováno v:
Leukemia Research Reports, Vol 14, Iss, Pp 100215-(2020)
Leuk Res Rep
Leukemia Research Reports
Leuk Res Rep
Leukemia Research Reports
The authors declare no conflict of interest
Aims In our single-center retrospective study we evaluated whether level of different checkpoint molecules in bone marrow biopsies at diagnosis affect the clinical course of patients with myelodysplast
Aims In our single-center retrospective study we evaluated whether level of different checkpoint molecules in bone marrow biopsies at diagnosis affect the clinical course of patients with myelodysplast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf000586e433e2ed27f6ec2dd80b9ac8
http://www.sciencedirect.com/science/article/pii/S2213048920300212
http://www.sciencedirect.com/science/article/pii/S2213048920300212
Autor:
Sergey V. Lapin, Maria V. Barabanshikova, Julia J. Vlasova, Boris V. Afanasyev, Ivan S. Moiseev, Maria Ivanova, Irina A Dubina, Elena V. Morozova
Publikováno v:
Oncology Research and Treatment. 40:574-579
Background: Chronic myeloproliferative neoplasms are characterized by clonal hematopoiesis and persistent inflammatory reaction. In this study, the clinical significance and prognostic impact of several inflammatory markers were evaluated in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c638f67e242a6527d89b8daec1dd974
https://doi.org/10.1159/000477253
https://doi.org/10.1159/000477253
Autor:
Julia J. Vlasova, Elena V. Morozova, Maria V. Barabanshikova, Kirill V. Lepik, Ivan S. Moiseev, Axel R. Zander, Elena V. Babenko, Anna G. Smirnova, Eugene A. Bakin, Olga S. Epifanovskaya, Nikolai Yu. Tcvetkov
Publikováno v:
Blood. 136:43-44
Background Immune checkpoint (IC) inhibitors (ICI) is a promising group of agents with potential effect in myelodysplastic syndrome (MDS). However, there is not enough data on the pattern of IC expression in MDS bone marrow, though this can guide fut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05f9774d8c79823275de5e60c52a2eef
https://doi.org/10.1182/blood-2020-141997
https://doi.org/10.1182/blood-2020-141997
Autor:
Ivan S. Moiseev, Julia J. Vlasova, Axel R. Zander, I. Barhatov, Elena V. Morozova, TL Gindina, Ludmila S. Zubarovskaya, Sergey N. Bondarenko, Maria V. Barabanshikova, Aleksandr D. Kulagin, Ksenia Jurovskaya
Publikováno v:
Blood. 136:29-30
Introduction: In spite of the widespread use of second- and third-generation tyrosine kinase inhibitors (TKIs) the prognosis of patients with advanced phase CML (accelerated phase (AP) or blast crisis (BC)) is still dismal. The aim of this study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bb0146d36d2d7636a798cd1088fb7f2
https://doi.org/10.1182/blood-2020-139452
https://doi.org/10.1182/blood-2020-139452
Autor:
I. Barhatov, Elena I. Darskaya, Tatjana Alexandrovna Rudakova, Maria V. Barabanshikova, Gennadij Georgievich Rodionov, Boris V. Afanasyev, V. Baykov, Ivan S. Moiseev, Elena Surkova, Sergey N. Bondarenko, Sergey Ivanovich Moiseev, Elena V. Morozova, Alena I. Shakirova, Alksandr Leonidovich Alyanski, Sergey V. Lapin, Julia J. Vlasova, Inna Edvardovna Ushal
Publikováno v:
Acta haematologica. 144(2)
Introduction: This prospective study evaluated a calcineurin inhibitor-free graft-versus-host disease (GVHD) prophylaxis regimen of ruxolitinib in combination with post-transplant cyclophosphamide (PTCy). Patents and Methods: Twenty patients with pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eba83f1b1cfeab44b9d55bd91d3e8fb6
https://pubmed.ncbi.nlm.nih.gov/32814312
https://pubmed.ncbi.nlm.nih.gov/32814312
Autor:
Vjacheslav Mikhailovich Savrasov, Boris V. Afanasyev, Maria V. Barabanshikova, Andrey Jurjevich Korolkov, V. Baykov, Ivan S. Moiseev, Igor Nikolaevich Zubarovsky, Julia J. Vlasova, Anna V. Botina, Elena I. Darskaya, Elena V. Morozova
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 12, Iss 3, Pp 140-145 (2019)
Background: Allogeneic hematopoietic stem cell transplantation (alloHSCT) is the only treatment option with curative potential in patients with myelofibrosis (MF). The aim of our study was to evaluate the safety of splenectomy before alloHSCT in MF p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91b48a1ad210850dbc6532978cd25a97
https://pubmed.ncbi.nlm.nih.gov/30978308
https://pubmed.ncbi.nlm.nih.gov/30978308
Autor:
Ildar M. Barkhatov, Artem Tishkov, Alexandr Dmitrievich Kulagin, E.A. Bakin, Elena V. Morozova, Maria V. Barabanshikova, Dmitrii Sergeevich Bug, Ivan S. Moiseev, Nikolay Yurevich Tcvetkov, Alena I. Shakirova, Ekaterina Andreevna Izmailova, Natalya Vitalievna Petuhova
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 3, p e0248430 (2021)
PLoS ONE, Vol 16, Iss 3, p e0248430 (2021)
A number of sequencing studies identified the prognostic impact of somatic mutations in myelodysplastic syndrome (MDS). However the majority of them focused on methylation regulation, apoptosis and proliferation genes. Despite the number of experimen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::634ad7965b73479fbc00fe19801171d6
https://doi.org/10.1371/journal.pone.0248430
https://doi.org/10.1371/journal.pone.0248430